Kiran Mazumdar-Shaw names niece Claire Mazumdar as successor at Biocon. Explore the leadership transition, strategy, and future plans.
'Leadership is about understanding how a business works, how it is shaped, built, and expanded.'
Biocon chief Kiran Mazumdar-Shaw met with Karnataka's Chief Minister and Deputy Chief Minister on Diwali, amidst ongoing concerns about Bengaluru's infrastructure.
The penalty collected from Mazumdar-Shaw will be donated to a charitable organisation of her choice.
Biocon CMD Kiran Mazumdar-Shaw has been named in the world's top 100 'effective and talented' people by US-based 'Scientific American' magazine.
While mostly corporates, including established names and little-known ones, went for the top-denomination bonds, there were also several individuals who bought multiple such bonds.
Beyond her avatar as the head of a multi-crore biotech company, Kiran Mazumdar-Shaw is a powerful voice of change for the city she lives in.
'I have added to the covid count by testing positive. Mild symptoms and I hope it stays that way,' the 67-year-old biotechnology industry veteran said in a tweet.
The story of Kiran Mazumdar-Shaw is one of grit, self confidence and courage. If today she is one of the most successful entrepreneurs in the world, it is because of her determination.
Kriti Mehra (ISB Class of 2010) shares her experience of meeting Kiran Mazumdar Shaw, CEO of Biocon.
Biocon chairperson and managing director Kiran Mazumdar-Shaw is in a firefighting mode, as the company she founded was forced to call off a blockbuster deal with global pharmaceutical major Pfizer.
The settlement with Sebi was seen as Infosys admitting guilt of the lapse, clearing out any legal or regulatory challenges and preparing ground for new chief executive officer Salil Parekh.
The annual list of 'Heroes of Philanthropy', compiled by Forbes Asia magazine, features a total of 48 people from the the Asia-Pacific region, including countries like China, Singapore, Hong Kong and Indonesia.
Testing only those with symptoms is not such a great idea. A lot of asymptomatic people are also positive. Its also important to do some amount of random testing in the clusters. You need to do lot more testing. The more you test, the more positives you get. Only redeeming feature is that the number of those getting into ICU or dying is not huge, she said.
"Karnataka has always forged inclusive economic development and we must not allow such communal exclusion- If ITBT became communal it would destroy our global leadership. @BSBommai please resolve this growing religious divide," Mazumdar-Shaw said.
Sitharaman, who is not known to reply to comments made on her Twitter handle, instantly choose to respond to drug-maker Biocon chairman Kiran Mazumdar-Shaw's criticism of lack of fiscal measures to support growth.
"Tendulkar's attorney said the cricket player's investment is legitimate and has been declared to tax authorities. Shakira's attorney said the singer declared her companies, which the attorney said do not provide tax advantages. Schiffer's representatives said the supermodel correctly pays her taxes in the UK, where she lives," it notes.
Kiran Mazumdar-Shaw talks to Nikita Puri about her book Mythbreaker.
A day after she praised Rohan Murthy's performance at Infosys' board meeting, the firm's newly-appointed independent director and Biocon head Kiran Mazumdar Shaw on Wednesday apologised for the remarks.
Refutes claims of differences between board, founders and Sikka; board needs to do better scrutiny, says Mohandas Pai.
Biocon aims to become the world's leading insulin company, capitalising on larger pharmaceutical rivals' strategic shift towards newer, high-margin GLP-1 diabetes therapies. The company plans to expand its insulin presence across 80 markets, focusing on value maximisation and addressing the indispensable need for insulin, particularly for Type-1 and late-stage Type-2 diabetics.
The entrepreneur reveals interesting nuggets about her life and career.
Karnataka Deputy Chief Minister D K Shivakumar responds to criticism regarding Bengaluru's infrastructure, while industry leaders and opposition members voice their concerns.
Lalit Modi posted a social media video from Vijay Mallya's 70th birthday party in London, referring to the pair as the 'two biggest fugitives' of India.
Proxy advisory firms say the praise on Twitter was uncalled for.
'I want to tell big IT companies and others that such things (pothole issue) are everywhere, we are doing our job. It is there across the country, but we have a duty, we will do it'
After registering encouraging data from oral insulin trials, Biocon is looking to partner on this with global pharma firms.
Learn how the founder of India's first and largest biotechnology company dealt with failure and achieved success.
Bengaluru is at a critical juncture, where its economic model, reliant on attracting and retaining skilled professionals, is directly threatened by a measurable decline in urban quality of life, point out Shishir Gupta and Rishita Sachdeva.
'We do not need short-term measures but long-term ones. Companies seem to have given up on the infrastructure part. Long delays are fuelling more traffic crisis.'
Addressing aspiring entrepreneurs, Biocon Chief Shaw adviced them never to fear failure.
An expert committee in Karnataka has concluded that there is no association between premature cardiovascular disease and a prior history of Covid-19 infection or Covid vaccination. The report suggests that common risk factors like hypertension, diabetes, and smoking are more likely causes.
On her first visit to any state in the Indian Union after being sworn in as President of the Republic, Rashtrapati Droupadi Murmu was felicitated in Bengaluru by some of that city's luminaries.
Femina celebrated their 60th anniversary with an iconic cover featuring Deepika Padukone, PV Sindhu and Kiran Mazumdar-Shaw.
"My view on taxation levels in India is that it is at a reasonable level and I think what is more important is how the government uses taxpayers' money," said Kiran Mazumdar-Shaw, the Chairman and Managing Director of Biocon, India's largest biotech company by revenue, said.
At the meeting of the Board of Governors of IIM Bengaluru held on February 11, the chairperson, Mukesh D Ambani, expressed his decision to step down, IIM-B said.
Raising overseas debt has become prohibitively expensive due to the depreciating rupee.
The company has received approval from the Drugs Controller General of India (DCGI) to market Itolizumab injection 25mg/5mL solution for emergency use in India for the treatment of cytokine release syndrome in moderate to severe acute respiratory distress syndrome (ARDS) due to COVID-19.
When Biocon chairperson Kiran Majumdar-Shaw - well known for raising issues ranging from lack of civic services in Bengaluru to climate change - decided to take on the Indian stock market regulator, the Securities and Exchange Board of India (Sebi), she forced the Indian corporate world and legal community to take notice. In an interview to Business Standard, Majumdar-Shaw called a Sebi order to impose a fine on insider trading charges against a Biocon employee and an external consultant an "Agatha Christie" fiction, which destroyed the reputation of "innocent people". "The order is pure harassment and has caused huge reputational damage to us and goes against the principles of good governance promised by this government," Mazumdar-Shaw said. "We will certainly appeal this," she added.
The four women have a collective wealth of $11.3 billion and account for a little more than three per cent of the total net worth of all on the coveted list whose collective wealth amount to $346 billion.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances